Velan (VLN) Q1 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2027 earnings summary
14 Jul, 2026Executive summary
Birch Hill's acquisition of a majority interest was completed on June 15, 2026, marking a new strategic chapter and strengthening leadership in core markets.
Leadership transition included a new board chair, additional Birch Hill nominees, and a majority of independent directors.
Q1 results were below the prior year, mainly due to geopolitical and regional conflicts impacting customer activity, order timing, and shipment schedules.
Transformation plan underway to optimize operations, modernize facilities, and support profitable growth.
Net loss from continuing operations was $9.4 million ($0.44 per share) versus net income of $17.8 million ($0.83 per share) last year, which included a $23.1 million non-recurring tax recovery.
Financial highlights
Q1 sales were $57.8 million, down from $72.2 million year-over-year, primarily due to deferred shipments from North American and Italian operations.
Bookings totaled $48 million, compared to $78.2 million last year, reflecting market challenges.
Gross profit was $11.4 million (19.6% margin), down from $20.6 million (28.6% margin) last year, mainly due to lower business volume and increased provisions.
Adjusted EBITDA was -$2.1 million, versus +$3.8 million last year; adjusted net loss was $6.9 million, compared to adjusted net income of $0.1 million.
Cash and cash equivalents stood at $34.6 million at quarter end.
Outlook and guidance
Backlog stood at $275.1 million, with 70.7% expected to be delivered within 12 months.
Majority of deferred shipments and bookings expected to be recaptured by fiscal year-end.
Anticipates growth in nuclear, defense, and energy markets, with strong opportunity pipeline and transformation initiatives supporting long-term outlook.
Focus on operational excellence and scalable infrastructure to support future growth.
Latest events from Velan
- Bookings up 63%, sales up 22.8%, net income positive, and record backlog driven by nuclear demand.VLN
Q2 20259 Jul 2026 - Sales and backlog grew in 2026, with strong liquidity and major asset sales completed.VLN
Q4 202615 May 2026 - Bookings and backlog improved, supporting growth and cash flow focus for 2025.VLN
AGM 20243 Feb 2026 - Q1 sales up 14.5%, gross margin 30.7%, backlog $528.3M, and major nuclear deal signed.VLN
Q1 20253 Feb 2026 - Strong backlog, major asset sale, and ownership transition marked Q3 2026.VLN
Q3 202615 Jan 2026 - Q3 saw 18.1% sales growth, margin gains, and risk reduction from major divestitures.VLN
Q3 202510 Jan 2026 - Shareholders approved the $201.1 million sale of French subsidiaries to Framatome.VLN
EGM 202526 Dec 2025 - Sales and margins surged, with divestitures and a special dividend boosting future prospects.VLN
Q4 202524 Nov 2025 - 18.6% sales growth, margin gains, and record cash drive a higher dividend and strong outlook.VLN
Q1 202616 Nov 2025